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Abstract
Background: Global migration from hepatitis B endemic countries poses a significant public health challenge in
receiving low-prevalence countries. In the UK, Chinese migrants are a high risk group for hepatitis B. However, they are
an underserved population that infrequently accesses healthcare. This study sought to increase understanding of the
determinants of hepatitis B testing and healthcare access among migrants of Chinese ethnicity living in England.
Methods: We sought to obtain and integrate insights from different key stakeholders in the system. We conducted six
focus group discussions and 20 in-depth interviews with community members and patients identifying themselves as
‘Chinese’, and interviewed 21 clinicians and nine health service commissioners. Data were thematically analysed and
findings were corroborated through two validation workshops.
Results: Three thematic categories emerged: knowledge and awareness, visibility of the disease, and health service
issues. Low disease knowledge and awareness levels among community members contributed to erroneous personal
risk perception and suboptimal engagement with services. Limited clinician knowledge led to missed opportunities to
test and inaccurate assessments of infection risks in Chinese patients. There was little social discourse and considerable
stigma linked to the disease among some sub-sections of the Chinese population. A lack of visibility of the issue and
the population within the health system meant that these health needs were not prioritised by clinicians or
commissioners. Service accessibility was also affected by the lack of language support. Greater use of community
outreach, consultation aids, ‘cultural competency’ training, and locally adapted testing protocols may help.
Conclusions: Hepatitis B among migrants of Chinese ethnicity in England can be characterised as an invisible disease in
an invisible population. Multi-modal solutions are needed to tackle barriers within this population and the health system.
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Background
There are an estimated 326,000 persons chronically in-
fected with hepatitis B virus (HBV) in the UK [1]. In low
prevalence countries such as the UK, chronic infection, pre-
dominantly acquired abroad, accounts for much of the bur-
den of hepatitis B [2]. Population groups who are more
likely to be infected include migrants from high prevalence
countries such as China and other Southeast Asian coun-
tries (including Hong Kong, Vietnam and Malaysia among
others). Though China has recently been classified as
having a high intermediate prevalence, (due to a sharp de-
crease in prevalence in children following the implementa-
tion of universal immunization) [3], the disease prevalence
is up to twenty times higher among individuals self-
identifying as ‘Chinese’ in the UK than in the British general
population [2, 4, 5]. Migration-related chronic HBV infec-
tion is emerging as a significant public health issue in many
western countries, increasing both the burden of disease as
well as risks of disease transmission locally [6].
Prior research suggests that high risk ethnic minority
groups are often underserved with low access to testing
and healthcare by these groups previously reported in
the UK [6, 7] and elsewhere, particularly the US and
Canada [8–11]. Initiatives to boost the uptake of HBV
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testing in migrant Chinese populations have been tried,
such as the Jade Ribbon campaign in San Francisco and
BeFreeNYC in New York, with variable results [8, 9, 11].
Most of these initiatives have focused on ‘liver cancer
prevention’ and sought to address perceived deficits in
knowledge and disease awareness in these communities
[12, 13]. Several studies identified obstacles to testing
such as financial barriers (e.g. user fees or lack of health
insurance), language barriers, and lack of familiarity with
the host country’s health system [14, 15]. Other studies
have found that opportunities for testing are often
missed due to low levels of knowledge and disease
awareness among clinicians [15–18].
The roles of health service planners and health systems
are also rarely studied. In the UK, hepatitis B-related
healthcare is provided through a range of different
agencies – infectious disease screening is usually provided
opportunistically through primary healthcare and commu-
nity services, whilst treatment and long-term disease
monitoring is delivered through specialist hospital-based
services. These services are commissioned and funded
separately by different agencies such as the local author-
ities, local clinical commissioning groups and the National
Health Service at the regional or national level. Whilst
there is a universal infectious diseases screening
programme in pregnancy, the UK has adopted a policy of
selective immunisation of newborns at highest risk of in-
fection. It has been recognised that this immunisation pol-
icy poorly protects existing or new migrants with chronic
HBV infection from high prevalence countries [1].
With increasing numbers of Chinese migrants globally
[19, 20], health issues linked to hepatitis B present new
challenges to health systems in receiving countries. How-
ever, outside North America, there is a dearth of studies
about hepatitis B in migrant Chinese populations. This
paper reports on a multi-perspective qualitative study in
the UK that explores how migrant Chinese populations,
clinicians and commissioners understand and experience
this disease, and how these understandings and experi-
ences impact on hepatitis B testing and healthcare access.
Methods
Study aim and design
The overall study aim was to identify barriers and en-
ablers of hepatitis B testing and healthcare access by mi-
grants of Chinese ethnicity living in England. These
processes were explored sequentially through a series of
qualitative investigations with community members and
patients self-identifying as ‘Chinese’, healthcare practi-
tioners, as well as managers and clinicians responsible
for the planning and strategic purchasing of health ser-
vices (referred to as ‘commissioners’). This approach was
adopted as the uptake of HBV testing and healthcare ac-
cess was thought likely to be influenced by complex
interactions between various stakeholders, the health
system and the wider health policy arena [21]. This
multi-perspective approach, a unique strength of this
study, sought to integrate and contextualise the know-
ledge and behaviours of migrant Chinese individuals, cli-
nicians and commissioners within the backdrop of
current health policy, organisation and delivery.
Setting
This study was conducted between September 2013 and
September 2015 in South Yorkshire, England. We defined
our study population broadly to include any individual who
self-identified as Chinese. This includes not only migrants
born in China, but also those originating from other parts
of East and Southeast Asia, such as Malaysia, Taiwan, and
Vietnam, where there are established Chinese communities.
They include different migration waves (including place of
origin, time of migration) as well as different generations of
migrants (e.g. children of first generation migrants). In
addition, the Chinese communities in South Yorkshire are
also geographically dispersed in the region. As such, the
label ‘Chinese’ covers a heterogeneous group of individuals
with diverse linguistic and cultural heritage and varied so-
cioeconomic profiles.
Community-level data collection
Six focus group discussions were conducted involving 31
Chinese adults resident in South Yorkshire recruited
through community groups, local venues and via snow-
balling. The focus groups were organised around natural
groupings to facilitate participation. They included
mothers with young children, elderly residents, univer-
sity students, parents of children attending a Chinese
school, and a Chinese community centre group. We
used a case vignette developed from initial ethnographic
field work and a topic guide to facilitate discussions (see
Additional file 1). A multi-lingual researcher facilitated
three focus group discussions in Mandarin and three in
Cantonese.
Subsequently, 20 in-depth face-to-face individual inter-
views were conducted with new participants recruited
using the same recruitment channels as for the focus
groups. Interviewees included 13 who reported having
HBV infection, three relatives of individuals who had
HBV infection, and four community workers. Interviews
explored individual narratives and patient journeys. Pre-
liminary findings from the focus group discussions in-
formed the interviews and enabled some issues to be
explored in greater depth, such as stigma and knowledge
sources. Written informed consent was sought from all
participants, and participants received reimbursements
of their travel expenses for their involvement in the
study where required. The interview guide used for the
community interviews are provided in Additional file 2.
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Health service-level data collection
Individual, semi-structured interviews with clinicians
were conducted to explore behaviour and attitudes to-
wards hepatitis B testing and referral, as well as their
personal experiences of dealing with hepatitis B and pa-
tients identified as ‘Chinese’. We recruited clinicians
who were involved in hepatitis B care or provided
healthcare to Chinese patients through purposive, con-
venience and snowballing sampling in order to obtain a
range of views. We interviewed 21 clinicians drawn from
five localities from different settings (hospitals, primary
care and the community) and from different specialities
(primary care, infectious diseases, sexual health, nephrol-
ogy, rheumatology and midwifery services). Interviews
were guided by an interview schedule (see Additional file 3)
which drew on our initial literature review [22] and early
findings from the community study.
Commissioning-level data collection
We also purposively sought and interviewed clinicians
and managers involved in commissioning or managing
hepatitis B services or health services for ethnic minority
groups. Potential participants were identified with the
help of our expert advisory group, and existing links
with various commissioning organisations. Snowballing
was used to identify other key individuals who held rele-
vant roles. Nine participants were recruited that in-
cluded directors of public health, consultants in public
health and communicable disease control, and senior
commissioning managers working across a range of dif-
ferent commissioning organisations at local, regional
and national levels. Individual interviews were con-
ducted face-to-face using an interview schedule of open-
ended questions (see Additional file 4) to explore partici-
pants’ awareness and knowledge of the disease, attitudes,
perception of risk in the Chinese population, as well as
perceived individual and system obstacles to the
commissioning and delivery of relevant services.
Following written informed consent, focus group discus-
sions and individual interviews were conducted in mutu-
ally convenient venues either in community venues,
workplace or university setting, and lasted between
40 min and two hours. The interviews and discussions
were audio recorded with the participants’ consent and
carried out on the condition of participant anonymity.
Data management, analysis and integration
Audio recordings were transcribed verbatim and subse-
quently translated where necessary for further analysis.
For the community study, a set of thematic codes was
developed drawing on our literature review [22] and ini-
tial ethnographic fieldwork. The coding scheme was it-
eratively developed by reading and re-reading the
transcripts and through research team discussions. Once
agreed, the thematic codes were applied systematically
across the group discussion and individual interview
transcripts. For the subsequent studies of clinicians and
commissioners, deductive and inductive interpretive ap-
proaches were used to identify key themes. Descriptive
coding and process coding were used to summarize pas-
sages of data and thematic content analysis was applied
to organise and consolidate relevant themes [23].
Emergent themes from the different studies were inte-
grated through a series of team workshops to identify
key factors operating at individual, family, community
and health service level that shape access, experience
and outcomes of healthcare. We looked for matching
themes and links between emergent themes, explored
discordant themes and sought to understand reasons
that could explain the discordance. Disagreements were
discussed until consensus was reached. Complementary
themes were grouped and re-grouped into higher
themes and are presented in the following section.
Two validation workshops were conducted in Sheffield
and London with stakeholders from across the country.
There was representation from Public Health England,
local authorities, clinical networks, primary care and
Chinese community organisations. Participants included
hospital physicians, general practitioners, commis-
sioners, consultants in public health and communicable
disease control, nurses, immunisation leads and commu-
nity representatives. Stakeholders were identified with
the help of our Expert Advisory Group, and purposively
selected in order to have a breadth of perspectives. The
workshops were used to assess the generalisability of the
findings to other parts of the country.
Results
A summary of participants’ characteristics is provided in
Tables 1 and 2. Of the 51 community participants, only
one turned out to have been born in the UK. This indi-
vidual was retained in the study as it was judged not ap-
propriate to exclude this individual from the focus group
discussion that they were part of.
Of the 23 clinicians interviewed, 12 were women and
11 were men. They included three who self-identified as
Chinese, two South Asians, two Black Africans and 14
White British.
The interviews and focus group discussions generated
rich material within which three major thematic categor-
ies were identified (Tables 3, 4 and 5). One group of
themes clustered around knowledge levels, as well as be-
liefs and attitudes of the three stakeholder groups. An-
other group pertained to the visibility of the issue and
its priority relative to other competing demands. The
third group were concerned with how services were con-
figured and delivered. Below we summarise the main
findings that were arrived at through the integrated
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analysis within and across the datasets. Selective quota-
tions are provided in Table 3 to illustrate the type of data
that was generated around particular themes.
Poor knowledge, awareness, beliefs and attitudes
There was poor knowledge of the disease amongst the
Chinese participants interviewed, as well as among the
clinicians and commissioners (Table 3). All three groups
had knowledge gaps related to transmission routes,
disease prevalence within the Chinese populations, and
associated health complications. There was a lack of
awareness of the asymptomatic nature of the infection
among Chinese participants which contributed to de-
layed health-seeking and an erroneous underestimation
of their personal risk of infection. Many were unaware
of services available in the UK, and did not appreciate
the need for long-term disease monitoring in those with
chronic infections.
Poor understanding was evident among in-depth inter-
view respondents who reported having the infection as
well as those who participated in the focus group discus-
sions. For example, some Chinese patients could not
Table 1 Community participants’ characteristics
Focus group
participants (n = 31)
In-depth
interviewees
(n = 20)
Age-group (years)
18–34 7 2
35–44 15 6
45–54 3 2
55–64 3 2
65–74 2 7
75+ 1 1
Gender
Female 27 14
Male 4 6
Country of birth
China 15 15
Taiwan 5 0
Hong Kong 4 5
Vietnam 4 0
Malaysia 1 0
Brunei 1 0
UK 1 0
Years lived in the UK
0–4 6 1
5–9 6 3
10–19 10 10
20+ 9 6
Educational level
Primary 2 2
Secondary 6 10
College/vocational school 5 0
Graduate 7 2
Postgraduate 11 5
Other 0 1
Current employment status
Employed 11 5
Self-employed 2 2
Unemployed 1 3
Student 4 1
Homemaker 10 2
Retired 3 7
Annual household income
< £25,000 9 7
£25,000–£49,000 11 4
£50,000+ 2 0
Don’t know 9 9
Table 1 Community participants’ characteristics (Continued)
Focus group
participants (n = 31)
In-depth
interviewees
(n = 20)
Marital status
Married 24 10
Single, never married 5 1
Divorced/separated 1 6
Widowed 1 3
Household size
1 3 3
2–3 11 9
4 12 4
5+ 5 3
Table 2 Characteristics of clinical participants
Setting Practitioner type Number
interviewed
General Practice General practitioner 4
Asylum Health Services General practitioner 4
Community & Hospital
Midwifery Services
Midwife 3
Sexual Health Services Genito-urinary medicine
doctor
Health promotion
specialist
4
Hospital services Hospital doctor
Dentist
6
Other allied health service Community link workers 2
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understand why tests were carried out on them but no
treatment was provided (these patients presumably did
not have active disease that required treatment and were
probably being managed conservatively). This led to
follow-up consultations being perceived to be “a waste of
time”. Some Chinese participants expressed a mistrust of
western medicine. Self-medication was commonly re-
ported in the focus groups, including the use of traditional
Chinese medicine and “food therapy” where certain herbal
stews and drinks were consumed on health grounds “to
detoxify the liver”. Importantly also, focus group discus-
sions indicated that the belief that HBV is transmissible
through shared food utensils was widespread. Community
respondents reported difficulties in accessing reliable
information in England and relied on Chinese language
websites that were found to be inaccurate when examined
by our clinical researchers and multi-lingual researcher.
Experience of stigma associated with the disease was
evident among some, but not all, the community respon-
dents, illustrating important heterogeneity within the
group of people identifying as ‘Chinese’. Some partici-
pants voiced concerns of the repercussions of a HBV
diagnosis such as the potential loss of employment and
social exclusion. Some of this stemmed from their past
experience of the disease’s stigma in their home coun-
tries – some focus group respondents and interview
participants recounted how in their home countries in-
fected persons were seen as a “public nuisance”. The
Table 3 Poor knowledge, beliefs and perceptions of the population and the disease by the community, clinicians and
commissioners
Themes Definitions Sample quotes
Knowledge of the disease
among community members
and patients
What the Chinese know about the disease
and services (including myths and
misunderstandings)
“[We] really know nothing about this (disease).” (Community focus group)
“In China we heard that it’s curable. How come it becomes incurable
in the UK?” (Community focus group)
‘Are there services? Are they reliable?’ (Community focus group)
What are the cultural norms, beliefs and
expectations
“In China there are all sorts of stuff that doctors would prescribe to us
to strengthen the immunity or detoxify the liver.” (Individual
interviewee, person with hepatitis B)
“What’s the point of taking all the blood tests, and (getting) no
treatment?” (Individual interviewee, person with hepatitis B)
What stigma exists about disease and
persons with the disease, as well as
associated services
“Chinese people believe HBV is easily transmitted through social
contacts, so HBV carriers are often treated as a public nuisance, who
are expected to inform people about his condition and keep their
distance” (Community focus group)
‘What if other people see me going into a sexual health clinic (for a
hepatitis B test)? What will they think about me?’ (Individual
interviewee)
Knowledge and attitudes of
clinicians and commissioners
What clinicians and commissioners know
of the disease and its management
“I reckon if you were to put down some hepatitis B results in front
of any of us … I suspect we would probably have to go and have a
little read on the internet or in the books.” (Clinician interviewee,
General practitioner)
“Because most of us trained more than ten years ago, there’s a
perception that well there’s no point in treating hepatitis. So there’s
something about educating the decision makers.” (Commissioner
interviewee, regional public health consultant)
What clinicians know about the Chinese and
how they deal with it
“… we need to be careful about stereotyping people … there is a
huge amount of in-group diversity.” (Clinician interviewee, hospital
physician)
“I’m hoping that there will be more ethnic training certainly in the
primary care setting because as a primary care GP I think there’s
desperately a lack of (training).” (Clinician interviewee, general
practitioner)
Perception of risk of infection in Chinese
persons
“… perception that (the Chinese) are much easier because they
don’t have any problems …” (Clinician)
“I am not sure that any GP is going to have a sufficient population
of Chinese to know that this is a major risk factor … If we make a
bizarre comparison, if you see a Black patient you think of sickle cell.
If you see a Chinese patient you don’t think about hepatitis B.”
(Commissioner interviewee, regional public health consultant)
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Taiwanese group of Chinese associated the disease with
“moral deficit”, caught by “sleeping around” or “using
needles”. Some participants believed, perhaps errone-
ously, that they were not at risk as they led a “stable life”,
did not use illicit drugs, and knew of no family members
with the disease. Although individuals could freely ac-
cess hepatitis B testing at genito-urinary medicine
clinics, we found that these services also carried stigma
and some Chinese participants worried about being seen
at these clinics because of their association with sexually
transmitted disease. Similarly, some respondents with
the infection feared that attending hepatitis clinics could
inadvertently result in the disclosure of their infection
status if they were seen there. Due to the fears and
shame of disclosure, patients also found it difficult to in-
form family members who were at risk. This situation
was worsened by the fact that their families could be
geographically dispersed.
Clinicians and commissioners interviewed also had
poor awareness of the disease prevalence in this commu-
nity. Many were unfamiliar with current testing proto-
cols and national guidance (i.e. NICE guidance CG 165
and PH43) [24, 25]. This meant they did not always
accurately perceive the risk of this disease in their Chinese
patients and missed opportunities to offer testing.
Low visibility of the issue
Another significant thematic group was the relatively
low visibility of hepatitis B and, more generally, the
health needs of the Chinese population in the UK
(Table 4). In the focus group discussions participants
noted that it was unusual to be discussing hepatitis B
and that there was little social discourse about hepatitis
B in the UK, both in the general public as well as within
Chinese communities. Some clinicians also expressed
the opinion that the Chinese used health services spar-
ingly and tended not to prioritise their own health. Our
community-level data supported this - new immigrants
reported giving low priority to their own health (espe-
cially for asymptomatic conditions) in the first few years
after arrival. Moreover, as they tended to be “undemand-
ing”, busy clinicians were unlikely to delve into their
health concerns fully or to proffer hepatitis B testing.
The lack of visibility also meant that both clinicians
and commissioners were unaware of the high disease
prevalence and attendant health needs in the Chinese.
Table 4 Low visibility and relative priority of the disease and Chinese population
Themes Definitions Sample quotes
Visibility of the issue How the community is perceived
by clinicians and commissioners
“I think the culture within each group makes a difference as well. I think rightly or wrongly,
the perception is that the Chinese immigrants tend to be more self-sufficient. The community
takes on … new entrants and support them in a way that means they are not as visible to
things like safeguarding or those other issues that flag them as a vulnerable group.”
(Commissioner interviewee, local commissioning manager)
“I think they probably do keep themselves to themselves… They are a quiet, self-contained
group it seems to me…So because they haven’t upset people their needs aren’t immediately
heard or seen.” (Clinician interviewee, general practitioner)
How the community behaves
that reduces its visibility
“(Eastern Europeans) … tend to demand more because they expect that … they ask a lot
of things when they see the doctor. Whereas the Chinese population … if you are a doctor
they do give you the respect. So that respect is there, which can be a barrier as well
because then you know some of their hidden frustration may not surface...” (Clinician
interviewee, Chinese-ethnicity general practitioner)
Level of public discourse of the
disease
“In China, HBV is frequently mentioned in everyday conversations, mass media, and internet.
HBV is a hot and heavy topic, rumours of transmission together with tragic stories of
suicidal HBV carriers encompassing people’s life.” (Community focus group)
“In the UK (Hepatitis B) is hardly mentioned anywhere and has caught no public attention.”
(Community focus group)
Role for advocates “There’s something about an advocate from within the community being a more successful
voice for the change in terms of within the community … It’s something about a
partnership between somebody who is willing to speak up for the community and
somebody who’s willing to represent the community in the discussions to get a priority for
it ...” (Commissioner interviewee, regional public health consultant)
“Well I do believe we need the help from the (Chinese) population to push their own cause
because other ethnic minority groups, when there’s a push from inside it’s more difficult to
argue against I think.” (Clinician interviewee, general practitioner)
Competing priorities “They will make you take lots of medicine, and all the tests. I really haven’t got that much
time.” (Community focus group)
“If it’s only one or two cases in the city, frankly it’s not going to get the attention it
deserves. If it’s hundreds or thousands, then it is more likely to. If it’s tens of thousands, it
certainly will.” (Commissioner interviewee, local public health director)
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Our commissioner respondents described the Chinese as
not being “needy” or a “problem group” and were per-
ceived to have relatively good health compared to other
ethnic groups. However, when pressed they admitted not
having any evidence to support this view. Language
barriers and the lack of strong advocates meant the
needs of the Chinese were not articulated to commis-
sioners. This situation was compared to that of some
Eastern European groups who, it was observed, were the
focus of considerably more vocal advocacy, such as from
local politicians. As the Chinese were fairly dispersed na-
tionally and present in small numbers in each locality, as
one commissioner described, they were “hidden in the
statistics”. In addition, other competing demands on lim-
ited commissioning resources meant their health needs
were not seen as a commissioning priority. Conse-
quently, respondents identified a need for greater advo-
cacy for this population group in general, and this health
issue in particular.
Structural barriers to health seeking and testing
Barriers also exist and operate at different levels within the
health system from the micro-level of the patient-provider
interaction through to the macro-level of health service
commissioning and policy making. At the patient-
provider level, the health professionals identified issues
such as the lack of language support and variable health
literacy of interpreters (Table 5). At the service level,
there was uncertainty as to whether HBV testing was
funded within existing contractual arrangements. This
meant clinicians were at times unsure whether they
could offer it free of charge to patients. Similarly, at the
policy level, commissioners reported there was a lack of
clarity as to who was responsible for commissioning
and providing HBV testing for this population. The
provision of HBV-related care to this population came
at a cost to healthcare providers and commissioners,
both in terms of time and resources, and there were
perverse disincentives within the system that deterred
the provision of HBV testing. One clinician explained
how they were not remunerated for carrying out rou-
tine HBV testing in primary care, and the identification
of infected individuals implied added healthcare costs,
as they were likely to be “over-followed up” (i.e. needed
to be seen several times in hospital), at a time when
cost-containment was a priority.
Table 5 Structural barriers to health seeking and testing
Themes Definitions Sample quotes
Health system issues Incentives, roles and responsibilities for
providing hepatitis B-related services
“Then it comes to something like hepatitis screening. Good evidence for it in my
opinion. Very logical to do. (But) there are all sorts of perverse incentives in the health
system: so you are not paid (to test), there is no reward for being good at doing it …
It costs you to do it, it takes time to do it, it’s hard to do it, it uses (hospital) referrals
and actually is one of the areas where very often people are often over followed-up …”
(Clinician interviewee, general practitioner)
How one navigates the health system “Maybe they have no understanding of the NHS system. Maybe they are new to this
country. I mean if somebody said to me we want you to go to Bulgaria and sort
yourself out a Hep B test, what the hell would I do? … that’s what we are trying to
do here and that’s difficult.” (Commissioner interviewee, local commissioning
manager)
How accessible are health services “Getting to see a doctor is harder than getting to meet an emperor.” (Community
focus group)
“They (the doctors) always sound as if you are making a mountain out of a molehill.
They make you feel that you just don’t need to come. So I try not to bother my GP
unless it is really serious...” (Community focus group)
Whether services are tailored to the
community
“I think the problem is that at the moment I don’t think services are particularly
commissioned to take into account different ethnic groups or different areas of need.”
(Commissioner interviewee, regional public health director)
“Going out into communities is definitely the way forward for certain groups
because … they wouldn’t (come in). Obviously language is a barrier and stigma.
They don’t like to come into hospital.” (Commissioner interviewee, local
commissioning manager)
“It is really to get the understanding of what they would like, how they would like it,
because anything we come up with might fall flat mightn’t it? That working with the
communities is the key thing.” (Commissioner interviewee, regional public health
consultant)
What consultation and communication
aids are present
“So if there’s a different language (involved) you know you definitely have to make
sure that what you’ve said is being understood. And then there’s a lot more checking
back as well when they answer.” (Clinician interviewee, general practitioner)
“So although we tend to use phone interpreters, you can never be assured exactly
what is being explained to (the patient).” (Clinician interviewee, general practitioner)
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The needs of Chinese patients were also not always ar-
ticulated and addressed due to language barriers. One
prominent theme that emerged from all of the focus
group discussions and many of the individual interviews
with Chinese participants, across all age groups and edu-
cational status, was of their struggle to explain themselves
to the health professionals. Similarly, the health profes-
sionals interviewed reported that consultations were more
time consuming and that it was more difficult to check
the Chinese patient’s understanding or concerns. Further-
more, the health professionals interviewed of Chinese eth-
nicity and those familiar with transcultural consultations
observed that Chinese patients were unlikely to challenge
their doctors’ decisions or to voice their concerns.
Several health professionals interviewed described their
Chinese patients as uncomplaining, “easy patients” who
rarely had any health problems. Many also had a poor
understanding of Chinese culture or awareness of the con-
siderable socioeconomic and cultural diversity within
Chinese populations. Some practitioners did acknowledge
their lack of knowledge and skills to adequately serve eth-
nic minority groups, and highlighted a need for further
communication skills training.
The health system’s failure to accommodate patients
with limited familiarity and poor English language skills
was a significant barrier that affected the ability of Chin-
ese patients to request tests and vaccinations for hepa-
titis B. Previous negative experiences of services in the
UK exacerbated matters: Chinese respondents cited diffi-
culties accessing services, rushed appointments, requests
for tests being questioned by clinicians, a perception that
doctors were withholding treatment due to budgetary
constraints, and a lack of choice and control over the
healthcare received. Some felt their concerns were trivia-
lised by doctors, and several said that they tried “not to
bother the GP unless it is really serious.”
Some clinicians acknowledged that services often did
not address the needs of ethnic minority groups such as
the Chinese and that there was a need for greater engage-
ment with the community and adaptation of services to
make them more patient-centered and responsive to local
needs. We did encounter some local adaptations such as
the use of community-based outreach services, “one-stop”
clinics, flexible clinic times, and the use of language sup-
port services and Chinese-speaking community link
workers. It was also suggested that reminders on the
patients’ electronic health records could help prompt
testing, and clinical protocols may help promote and
standardise offers of testing. Commissioner input was
highlighted as essential for creating an enabling envir-
onment for innovative tailored service approaches to
be devised. The involvement of commissioners was
also needed to ensure that these services would con-
tinue to be supported and funded.
Discussion
In common with prior research [6, 26–28], we identified
some individual and community-level factors that act as
obstacles to appropriate testing and treatment for hepa-
titis B, including low awareness of the disease; inaccurate
perceptions of personal infection risk; lack of familiarity
navigating the health system; and stigma (particularly
among some sub-groups). However, previously reported
studies of interventions that focus narrowly on address-
ing knowledge and perceptions in minority Chinese pop-
ulations have found weak, if any, effect on testing rates
[29–31]. This suggests other determinants may operate
and therefore different strategies may be required.
It was apparent from our study that clinician and com-
missioner knowledge and behaviours influenced their deci-
sions with regards to whether Chinese patients were tested,
or HBV-related services were provided, respectively. Stereo-
types and misunderstandings about the population exist,
reflecting a lack of cultural competence. Their lack of
awareness of the population’s risk of infection means that
opportunities to test are missed and hepatitis B-related ser-
vices are unlikely to be commissioned. Moreover, how
existing services were configured and delivered could ad-
versely affect their accessibility and acceptability to the
Table 6 Key recommendations
Community-level
▪ Improve knowledge about the disease, and awareness of the disease
in at-risk groups
▪ Raise awareness of the asymptomatic nature of disease
▪ Tackle misperceptions
▪ Tackle stigma both at the individual and community level
▪ Provide health system navigators and clarify entitlements to health
services
▪ Explore developing family support to influence testing and longer
term compliance
Healthcare practitioners and services
▪ Improve healthcare practitioners’ knowledge of the disease, and raise
their awareness of risk groups
▪ Develop cultural competency of staff. Be aware of in-group diversity
▪ Provide language support with health literate interpreters
▪ Train staff in the use of interpreters
▪ Make greater use of informational aids and tools such as patient
alerts in electronic health records
Commissioners, Service Managers and Policymakers
▪ Ensure adequate resourcing for implementation of testing
▪ Identify advocate to champion the issue to local decision-makers.
▪ Engender leadership and ownership of the agenda
▪ Develop a compelling narrative of need and the economic case
▪ Clarify roles and responsibilities for commissioning hepatitis B
services for migrants
▪ Develop joint collaborative commissioning where the responsibilities
are split
▪ Encourage and empower local innovation
▪ Recognise community diversity and tailor responses to local needs
and context
▪ Look to make services sustainable
▪ Increase accessibility of services - community-based/outreach services
may help
▪ Explore collaboration with other agencies and the voluntary sector
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population. This situation is compounded by uncertainties
with regards to who is responsible for commissioning and
providing these services following the recent restructuring
of health service design, purchasing and provision in
England since 2012. Furthermore, the structures and re-
sponsibilities continue to change and regional variations
exist.
Frontline clinicians may benefit from further education
and training to develop cultural competency as well as
communication skills to handle cross-cultural consulta-
tions. Other interventions that may help include the
provision of services delivered in community-settings, ser-
vices that operate more convenient flexible opening hours,
and the use of community link workers. Multi-component
interventions are likely to be needed but prior research has
not to-date determined the efficacy of the individual com-
ponents [12, 32]. Our study identified the following list of
recommendations that may be beneficial (Table 6).
Our findings echo previous work [33] that has highlighted
the importance of commissioner engagement, especially
when service adaptations are required in the context of re-
source constraints [34], in order to ensure that services are
sustainable and adequately resourced. As the affected com-
munities are diverse, interventions have to be tailored to
local needs and context. This requires the delivery of ser-
vices in different venues and ways, such as greater use of
community outreach services, in order to improve their ac-
cessibility. However, interventions seeking to improve test-
ing may still fail for a variety of reasons such as the short
term nature of the evaluation of the interventions, costs that
may be prohibitively expensive or deemed poor value for
money, or accessibility issues. For services to be commis-
sioned for the Chinese population, a compelling narrative of
need and the economic case for commissioners is required.
However, Chinese communities tend to be undemanding
and hidden. Consequently, strong advocates to champion
their needs to local decision-makers are needed. Greater
visibility of the issue is crucial as it has to compete against
other priorities that clinicians and commissioners have.
Stigma was a major theme in the data, operating at
the individual, community and structural levels. The
process of stigmatisation acts to keep people unin-
formed and stigma can also deter access to health ser-
vices. Furthermore, stigma may potentially influence
the priorities of health professionals and commissioners
that could lead to certain health issues being addressed
whilst others are ignored. The study findings also high-
light an important tension between health literacy and
illness representations among Chinese participants, cli-
nicians and commissioners (i.e. what is known about
hepatitis B compared to what an individual believes
about hepatitis B). This tension needs to be better
understood. Parallels can be drawn between HIV and
hepatitis B in Chinese communities, and potentially
useful insights could be extrapolated from research
on HIV-related stigma [35, 36].
The cultural competence of institutions and healthcare
workers needs to be further enhanced with an aim to
achieve equal treatment despite cultural barriers. Accessibil-
ity issues to be addressed include the poor levels of aware-
ness amongst clinicians and commissioners of the Chinese
community’s health beliefs, behaviour and needs. Services
have to ensure availability of effective language support with
interpreters who are health literate, and staff must be ad-
equately trained to make best use of interpreters. Greater
use of informational aids and tools may also help [27].
In addition, it may be useful to consider the role of
structural competency [37]. The clinical presentations of
people from marginalized groups are shaped not only by
cultural determinants, but also by multi-layered social,
economic and political processes as well as structural in-
equities, biases and blind spots that produce inequalities
in healthcare. Low levels of structural competency
among commissioners and some clinicians could explain
hepatitis B’s low visibility.
Furthermore, the UK previously had a targeted (selective
vaccination for high risk newborns) rather than universal
vaccination policy for hepatitis B as recommended by the
World Health Organization, in view of the low prevalence
of infection nationally. Consequently, vaccination pro-
grammes in the UK were unlikely to adequately protect
existing or newly immigrating individuals with chronic
HBV infection from high prevalence countries or their
contacts, especially children, who may be at risk [1]. Rou-
tine immunisations for hepatitis B are to be introduced
into the UK from the autumn of 2017 but will only cover
newborns and not older children.
Feedback from our workshops suggested that existing
health services should be encouraged to innovate and
adopt different approaches to better engage with the tar-
get community. There is also a need to engage health
commissioners in order to make this a priority for
commissioning. A national profile for this issue could
help raise this issue up local commissioning agendas.
National drivers are especially influential in directing ac-
tion locally when resources for commissioning are tight
[18]. Crucially, clarity of organisational responsibilities
for the commissioning and provision of hepatitis B ser-
vices for migrant groups is required.
Whilst community education is recognized to be benefi-
cial we need to explore further their informational needs
and how information can be successfully delivered in
practice. Further exploration of the role of family support
to influence testing and longer term compliance may also
be beneficial [38]. In the UK, the next steps needed are to
design and test approaches to boost healthcare access and
testing for hepatitis B in the migrant Chinese population.
Those individuals who have a positive test will need to be
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subsequently followed up by the relevant clinical services,
as well as informed that long term monitoring is import-
ant even in the absence of treatment.
As the participants were predominantly from SouthYork-
shire, the generalisability of the findings was a potential
limitation which we sought to address through the national
validation workshops. A key limitation was that we strug-
gled to recruit male participants, and especially young men,
as many were reluctant to do so or could not afford the
time due to work demands. We were also unable to recruit
Chinese individuals who were undocumented immigrants
or sex workers. Whilst they may be less representative of
the wider Chinese community, they are subgroups recog-
nized to have a higher risk of hepatitis B infection [3]. Many
of the barriers to hepatitis B testing and healthcare for these
groups are probably similar to those faced by the wider
Chinese community but there may be additional determi-
nants not uncovered by this study. Finally, there are poten-
tial limitations with data generation when dealing with a
sensitive topic – for example, participants may not wish to
disclose their infection status or that of their family mem-
bers. We were acutely aware of this and actively sought to
conduct our community interviews sensitively.
Conclusions
In a globalized world, public health systems often inad-
equately meet the needs of increasingly diverse multi-
cultural populations that manifest as inequalities in
health access. However, in the current global political
context there is a real risk that this issue is conflated
with arguments over national migration policy rather
than as a public health issue. Currently, hepatitis B in
the migrant Chinese in the UK is an invisible issue af-
fecting an invisible population. Multi-modal solutions
are required to address the various barriers that exist
both in the community and the health system.
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